PFE logo

Pfizer Inc. (PFE) Free cash flow

annual FCF:

$9.84B+$5.04B(+105.20%)
December 31, 2024

Summary

  • As of today (August 20, 2025), PFE annual free cash flow is $9.84 billion, with the most recent change of +$5.04 billion (+105.20%) on December 31, 2024.
  • During the last 3 years, PFE annual FCF has fallen by -$20.03 billion (-67.07%).
  • PFE annual FCF is now -67.21% below its all-time high of $29.99 billion, reached on December 31, 2022.

Performance

PFE Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

quarterly FCF:

-$1.20B-$2.97B(-167.76%)
June 29, 2025

Summary

  • As of today (August 20, 2025), PFE quarterly free cash flow is -$1.20 billion, with the most recent change of -$2.97 billion (-167.76%) on June 29, 2025.
  • Over the past year, PFE quarterly FCF has increased by +$1.22 billion (+50.39%).
  • PFE quarterly FCF is now -111.17% below its all-time high of $10.74 billion, reached on June 1, 2021.

Performance

PFE quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

TTM FCF:

$12.44B+$1.22B(+10.87%)
June 29, 2025

Summary

  • As of today (August 20, 2025), PFE TTM free cash flow is $12.44 billion, with the most recent change of +$1.22 billion (+10.87%) on June 29, 2025.
  • Over the past year, PFE TTM FCF has increased by +$7.63 billion (+158.59%).
  • PFE TTM FCF is now -60.86% below its all-time high of $31.77 billion, reached on March 1, 2022.

Performance

PFE TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

PFE Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+105.2%+50.4%+158.6%
3 y3 years-67.1%-116.2%-56.3%
5 y5 years-2.6%-138.7%-1.9%

PFE Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-67.2%+105.2%-113.2%+50.4%-58.5%+159.5%
5 y5-year-67.2%+105.2%-111.2%+50.4%-60.9%+159.5%
alltimeall time-67.2%+6566.1%-111.2%+82.0%-60.9%>+9999.0%

PFE Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$1.20B(-167.8%)
$12.44B(+10.9%)
Mar 2025
-
$1.77B(-69.5%)
$11.22B(+14.1%)
Dec 2024
$9.84B(+105.2%)
$5.80B(-4.3%)
$9.84B(+19.5%)
Sep 2024
-
$6.06B(-350.6%)
$8.23B(+71.0%)
Jun 2024
-
-$2.42B(-725.1%)
$4.81B(-5.8%)
Mar 2024
-
$387.00M(-90.8%)
$5.11B(+6.6%)
Dec 2023
$4.79B(-84.0%)
$4.20B(+58.6%)
$4.79B(-41.4%)
Sep 2023
-
$2.65B(-224.8%)
$8.18B(-44.1%)
Jun 2023
-
-$2.12B(-3045.8%)
$14.63B(-39.5%)
Mar 2023
-
$72.00M(-99.1%)
$24.16B(-19.4%)
Dec 2022
$29.99B(+0.4%)
$7.58B(-16.6%)
$29.99B(+9.8%)
Sep 2022
-
$9.09B(+22.6%)
$27.32B(-4.0%)
Jun 2022
-
$7.42B(+25.8%)
$28.45B(-10.5%)
Mar 2022
-
$5.90B(+20.1%)
$31.77B(+6.4%)
Dec 2021
$29.87B(+145.3%)
$4.91B(-51.9%)
$29.87B(+0.3%)
Sep 2021
-
$10.22B(-4.9%)
$29.77B(+40.9%)
Jun 2021
-
$10.74B(+169.2%)
$21.13B(+56.7%)
Mar 2021
-
$3.99B(-17.0%)
$13.48B(+10.7%)
Dec 2020
$12.18B(+20.6%)
$4.81B(+204.2%)
$12.18B(+17.0%)
Sep 2020
-
$1.58B(-49.0%)
$10.41B(-17.9%)
Jun 2020
-
$3.10B(+15.5%)
$12.67B(+9.3%)
Mar 2020
-
$2.68B(-11.8%)
$11.60B(+16.0%)
Dec 2019
$10.10B(-25.9%)
$3.04B(-20.9%)
$9.99B(-8.3%)
Sep 2019
-
$3.85B(+90.2%)
$10.90B(-7.2%)
Jun 2019
-
$2.02B(+87.3%)
$11.75B(-10.4%)
Mar 2019
-
$1.08B(-72.6%)
$13.11B(-3.8%)
Dec 2018
$13.63B(-6.5%)
$3.95B(-16.0%)
$13.63B(-14.7%)
Sep 2018
-
$4.70B(+38.5%)
$15.99B(+2.5%)
Jun 2018
-
$3.39B(+112.3%)
$15.60B(+4.3%)
Mar 2018
-
$1.60B(-74.7%)
$14.95B(+2.5%)
Dec 2017
$14.59B(+4.9%)
$6.30B(+46.3%)
$14.59B(+9.9%)
Sep 2017
-
$4.31B(+57.0%)
$13.27B(+0.0%)
Jun 2017
-
$2.74B(+122.5%)
$13.26B(-2.7%)
Mar 2017
-
$1.23B(-75.3%)
$13.63B(-2.0%)
Dec 2016
$13.90B(+5.4%)
$4.98B(+15.8%)
$13.90B(+7.2%)
Sep 2016
-
$4.30B(+38.4%)
$12.97B(-3.0%)
Jun 2016
-
$3.11B(+106.1%)
$13.37B(-5.1%)
Mar 2016
-
$1.51B(-62.8%)
$14.09B(+8.2%)
Dec 2015
$13.19B(-13.8%)
$4.05B(-13.8%)
$13.02B(-6.8%)
Sep 2015
-
$4.70B(+22.8%)
$13.97B(+6.0%)
Jun 2015
-
$3.83B(+774.0%)
$13.17B(+0.5%)
Mar 2015
-
$438.00M(-91.2%)
$13.10B(-14.4%)
Dec 2014
$15.30B(-6.1%)
$5.00B(+28.1%)
$15.30B(-0.7%)
Sep 2014
-
$3.90B(+3.8%)
$15.41B(-10.1%)
Jun 2014
-
$3.76B(+42.5%)
$17.14B(+1.4%)
Mar 2014
-
$2.64B(-48.4%)
$16.90B(+3.7%)
Dec 2013
$16.30B(+6.3%)
$5.11B(-9.2%)
$16.30B(+2.2%)
Sep 2013
-
$5.63B(+59.9%)
$15.95B(+6.1%)
Jun 2013
-
$3.52B(+72.7%)
$15.04B(-1.4%)
Mar 2013
-
$2.04B(-57.2%)
$15.25B(-3.1%)
Dec 2012
$15.33B(-16.5%)
$4.76B(+0.9%)
$15.73B(+0.6%)
Sep 2012
-
$4.72B(+26.6%)
$15.63B(+4.9%)
Jun 2012
-
$3.73B(+47.9%)
$14.89B(-10.9%)
Mar 2012
-
$2.52B(-46.0%)
$16.71B(-10.1%)
Dec 2011
$18.36B(+84.7%)
$4.66B(+17.0%)
$18.58B(-5.3%)
Sep 2011
-
$3.98B(-28.1%)
$19.63B(-10.9%)
Jun 2011
-
$5.54B(+26.1%)
$22.04B(+5.0%)
Mar 2011
-
$4.39B(-23.1%)
$21.00B(+111.2%)
Dec 2010
$9.94B(-35.4%)
$5.71B(-10.7%)
$9.94B(+15.2%)
Sep 2010
-
$6.39B(+42.1%)
$8.63B(+42.0%)
Jun 2010
-
$4.50B(-167.5%)
$6.08B(+4.4%)
Mar 2010
-
-$6.67B(-251.4%)
$5.82B(-62.1%)
Dec 2009
$15.38B(-5.8%)
$4.40B(+14.7%)
$15.38B(-6.1%)
Sep 2009
-
$3.84B(-9.5%)
$16.39B(+2.1%)
Jun 2009
-
$4.25B(+46.7%)
$16.05B(-2.4%)
Mar 2009
-
$2.89B(-46.5%)
$16.45B(+0.7%)
Dec 2008
$16.33B(+43.7%)
$5.41B(+54.4%)
$16.33B(+16.6%)
Sep 2008
-
$3.50B(-24.5%)
$14.00B(-4.8%)
Jun 2008
-
$4.64B(+67.2%)
$14.71B(+11.2%)
Mar 2008
-
$2.77B(-10.1%)
$13.22B(+16.4%)
Dec 2007
$11.36B(-26.2%)
$3.09B(-26.6%)
$11.36B(-6.1%)
Sep 2007
-
$4.21B(+33.2%)
$12.10B(+6.9%)
Jun 2007
-
$3.16B(+246.2%)
$11.32B(-11.8%)
Mar 2007
-
$912.00M(-76.2%)
$12.84B(-17.0%)
Dec 2006
$15.39B
$3.83B(+11.9%)
$15.47B(-1.9%)
DateAnnualQuarterlyTTM
Sep 2006
-
$3.42B(-26.8%)
$15.76B(+6.1%)
Jun 2006
-
$4.67B(+31.9%)
$14.86B(+10.6%)
Mar 2006
-
$3.54B(-14.1%)
$13.43B(+7.2%)
Dec 2005
$12.20B(-9.1%)
$4.12B(+63.8%)
$12.53B(-5.9%)
Sep 2005
-
$2.52B(-22.5%)
$13.32B(-13.6%)
Jun 2005
-
$3.25B(+23.1%)
$15.41B(+1.0%)
Mar 2005
-
$2.64B(-46.3%)
$15.27B(+11.1%)
Dec 2004
$13.41B(+61.7%)
$4.92B(+6.6%)
$13.74B(+10.4%)
Sep 2004
-
$4.61B(+48.6%)
$12.44B(+23.9%)
Jun 2004
-
$3.10B(+179.2%)
$10.04B(+21.7%)
Mar 2004
-
$1.11B(-69.3%)
$8.25B(-9.1%)
Dec 2003
$8.30B(+5.1%)
$3.62B(+63.3%)
$9.08B(+4.4%)
Sep 2003
-
$2.21B(+69.0%)
$8.70B(+3.6%)
Jun 2003
-
$1.31B(-32.5%)
$8.40B(-8.6%)
Mar 2003
-
$1.94B(-40.0%)
$9.19B(+9.1%)
Dec 2002
$7.90B(+15.4%)
$3.23B(+68.9%)
$8.43B(+20.2%)
Sep 2002
-
$1.92B(-8.8%)
$7.01B(-1.8%)
Jun 2002
-
$2.10B(+78.5%)
$7.13B(+3.7%)
Mar 2002
-
$1.18B(-35.3%)
$6.88B(-2.9%)
Dec 2001
$6.85B(+78.7%)
$1.82B(-10.9%)
$7.09B(-2.3%)
Sep 2001
-
$2.04B(+10.4%)
$7.25B(+5.8%)
Jun 2001
-
$1.85B(+33.5%)
$6.86B(+47.7%)
Mar 2001
-
$1.38B(-30.2%)
$4.64B(+15.9%)
Dec 2000
$3.83B(+152.8%)
$1.98B(+20.9%)
$4.00B(+40.0%)
Sep 2000
-
$1.64B(-547.1%)
$2.86B(+45.4%)
Jun 2000
-
-$367.00M(-149.2%)
$1.97B(-28.1%)
Mar 2000
-
$746.00M(-11.3%)
$2.74B(+80.7%)
Dec 1999
$1.51B(-12.3%)
$841.00M(+12.6%)
$1.51B(-9.8%)
Sep 1999
-
$747.00M(+85.4%)
$1.68B(+18.7%)
Jun 1999
-
$403.00M(-184.7%)
$1.42B(+5.0%)
Mar 1999
-
-$476.00M(-147.3%)
$1.35B(-22.0%)
Dec 1998
$1.73B(+151.7%)
$1.01B(+108.7%)
$1.73B(+98.1%)
Sep 1998
-
$482.00M(+43.9%)
$872.00M(+35.4%)
Jun 1998
-
$335.00M(-449.0%)
$644.00M(+26.3%)
Mar 1998
-
-$96.00M(-163.6%)
$510.00M(-23.0%)
Dec 1997
$686.00M(-46.9%)
$151.00M(-40.6%)
$662.00M(+24.9%)
Sep 1997
-
$254.00M(+26.4%)
$530.00M(-20.7%)
Jun 1997
-
$201.00M(+258.9%)
$668.00M(-15.5%)
Mar 1997
-
$56.00M(+194.7%)
$791.00M(-3.7%)
Dec 1996
$1.29B(+14.9%)
$19.00M(-95.2%)
$821.00M(-34.5%)
Sep 1996
-
$392.00M(+21.0%)
$1.25B(+13.8%)
Jun 1996
-
$324.00M(+276.7%)
$1.10B(+29.7%)
Mar 1996
-
$86.00M(-81.0%)
$849.70M(-24.5%)
Dec 1995
$1.13B(+37.7%)
$451.70M(+88.1%)
$1.13B(+17.1%)
Sep 1995
-
$240.10M(+233.9%)
$960.90M(+2.6%)
Jun 1995
-
$71.90M(-80.1%)
$936.60M(-11.7%)
Mar 1995
-
$361.40M(+25.7%)
$1.06B(+29.9%)
Dec 1994
$817.00M(+29.9%)
$287.50M(+33.2%)
$817.00M(-18.8%)
Sep 1994
-
$215.80M(+9.8%)
$1.01B(+3.9%)
Jun 1994
-
$196.60M(+67.9%)
$967.90M(+14.7%)
Mar 1994
-
$117.10M(-75.4%)
$844.20M(+34.3%)
Dec 1993
$628.80M(+373.5%)
$476.40M(+167.9%)
$628.80M(+121.8%)
Sep 1993
-
$177.80M(+143.9%)
$283.50M(+50.4%)
Jun 1993
-
$72.90M(-174.2%)
$188.50M(+39.2%)
Mar 1993
-
-$98.30M(-175.0%)
$135.40M(+2.0%)
Dec 1992
$132.80M(-47.7%)
$131.10M(+58.3%)
$132.80M(-27.7%)
Sep 1992
-
$82.80M(+318.2%)
$183.80M(+52.8%)
Jun 1992
-
$19.80M(-119.6%)
$120.30M(-37.3%)
Mar 1992
-
-$100.90M(-155.4%)
$191.90M(-24.4%)
Dec 1991
$253.80M(+8.2%)
$182.10M(+843.5%)
$253.80M(-20.8%)
Sep 1991
-
$19.30M(-78.9%)
$320.60M(+16.1%)
Jun 1991
-
$91.40M(-334.4%)
$276.10M(+4.2%)
Mar 1991
-
-$39.00M(-115.7%)
$264.90M(-15.4%)
Dec 1990
$234.60M(>+9900.0%)
$248.90M(-1087.7%)
$313.00M(+388.3%)
Sep 1990
-
-$25.20M(-131.4%)
$64.10M(-28.2%)
Jun 1990
-
$80.20M(+781.3%)
$89.30M(+881.3%)
Mar 1990
-
$9.10M
$9.10M
Dec 1989
$2.30M(-94.1%)
-
-
Dec 1988
$39.30M(-91.5%)
-
-
Dec 1987
$460.60M(-14.1%)
-
-
Dec 1986
$536.00M(-452.4%)
-
-
Dec 1985
-$152.10M(-125.0%)
-
-
Dec 1984
$608.40M(+50.3%)
-
-
Dec 1983
$404.80M(+16.1%)
-
-
Dec 1982
$348.70M
-
-

FAQ

  • What is Pfizer Inc. annual free cash flow?
  • What is the all time high annual FCF for Pfizer Inc.?
  • What is Pfizer Inc. annual FCF year-on-year change?
  • What is Pfizer Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for Pfizer Inc.?
  • What is Pfizer Inc. quarterly FCF year-on-year change?
  • What is Pfizer Inc. TTM free cash flow?
  • What is the all time high TTM FCF for Pfizer Inc.?
  • What is Pfizer Inc. TTM FCF year-on-year change?

What is Pfizer Inc. annual free cash flow?

The current annual FCF of PFE is $9.84B

What is the all time high annual FCF for Pfizer Inc.?

Pfizer Inc. all-time high annual free cash flow is $29.99B

What is Pfizer Inc. annual FCF year-on-year change?

Over the past year, PFE annual free cash flow has changed by +$5.04B (+105.20%)

What is Pfizer Inc. quarterly free cash flow?

The current quarterly FCF of PFE is -$1.20B

What is the all time high quarterly FCF for Pfizer Inc.?

Pfizer Inc. all-time high quarterly free cash flow is $10.74B

What is Pfizer Inc. quarterly FCF year-on-year change?

Over the past year, PFE quarterly free cash flow has changed by +$1.22B (+50.39%)

What is Pfizer Inc. TTM free cash flow?

The current TTM FCF of PFE is $12.44B

What is the all time high TTM FCF for Pfizer Inc.?

Pfizer Inc. all-time high TTM free cash flow is $31.77B

What is Pfizer Inc. TTM FCF year-on-year change?

Over the past year, PFE TTM free cash flow has changed by +$7.63B (+158.59%)
On this page